Dermata Therapeutics Statistics
NASDAQ: DRMAHealthcareBiotechnologyUSD
1.07-0.05 (-4.46%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Dermata Therapeutics by the numbers
Dermata Therapeutics has a market capitalization of $5.3 million based on 4.96M shares outstanding. With trailing EPS of $-4.19, Dermata Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 13.8% below its 50-day average and 24.6% below its 200-day average.
Average daily trading volume is 706.43K shares, or about $755,879 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
DRMA valuation vs. peer median
| Metric | DRMA | Peer median | Difference |
|---|---|---|---|
| Market cap | $5.30M | $5.29M | +0% |
| Avg. volume | 706.43K | 112.66K | +527% |
Peer median across 8 companies: CDIO, ENLV, LNAI, ADXN, PULM, XBIO, LIMN, XTLB.
Valuation
- Market cap
- $5.30M
- EPS (TTM)
- $-4.19
- Shares outstanding
- 4.96M
Price and trading
- Previous close
- 1.12
- Open
- 1.06
- Day range
- 1.06 – 1.07
- 52-week range
- 0.951 – 4.66
- Beta
- —
- Volume
- 6.80K
- Average volume
- 706.43K
Dividends and events
- Annual dividend
- None
- Next earnings date
- May 14, 2025
Additional statistics
- Market Cap
- 5.30M
- Forward Pe
- -0.28
- Eps
- -4.19
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 4.66
- Week52 Low
- 0.95
- Avg Volume
- 706.43K
- Shares Outstanding
- 4.96M
- Ma50
- 1.24
- Ma200
- 1.42
- Earnings Date
- May 14, 2025
- Pct From52w High
- -77.04%
- Pct From52w Low
- 12.51%